Skip to main content
OpenTrials
Completed

NCT Number: NCT02898545

Recurrent Atrial Fibrillation

This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Cincinnati Medical Center

Cincinnati, Ohio, 45219, United States

About this study

Eligible individuals with no previous history of atrial fibrillation or flutter who develop a limited episode of atrial fibrillation during a hospital stay for an acute medical illness or non-cardiothoracic surgery or procedure. Patients will be monitored for a period of 1 month using Medtronic SEEQ monitors for recurrence. Subjects will self assign to wear the SEEQ monitor or standard of care. Individuals with implanted cardiac devices capable of detecting atrial fibrillation will also be included.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Development of atrial fibrillation or flutter during a hospital stay following a non-cardiac procedure or acute medical illness
  • CHADS2VASc score of 2 or more

Exclusion criteria

  • Prior history of atrial fibrillation of flutter
  • Requiring ventilator support or in shock
  • Acute decompensated heart failure or EF =/< 40%
  • Greater than mild valvular heart disease
  • Other structural heart disease such as more than mild LVH, constrictive or restrictive cardiomyopathy
  • Hyperthyroidism uncontrolled at the time of diagnosis if known
  • Pulmonary embolism that requires thrombolysis or resulted in shock
  • Use of antiarrhythmic drugs (class I or III) at the time of discharge
  • Cardiothoracic surgery in the last 6 months

Treatment and study plan

SEEQ monitor

Device

An external cardiac rhythm monitor

Primary outcomes

  1. Recurrence of atrial fibrillation

    Time frame: 28 days

    The rate of recurrence of atrial fibrillation will be compared to the recurrence noted in the standard of care arm.

Sponsors and collaborators

Lead sponsor

University of Cincinnati

Other

Registry information

Acronym: Recurrent AF

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 13, 2016
Registry last updated
Aug 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.